Polen Capital acquired 15.5k Mirum Pharmaceuticals shares worth $1.15M. That's 0.00% of their equity portfolio (133rd largest holding). The stake costed the investor $691k, netting the investor a gain of 67% so far.
¡ Selling at Mirum Pharmaceuticals In other Mirum Pharmaceuticals news, SVP Jolanda ¡ on Mirum Pharmaceuticals About Mirum Pharmaceuticals (Free Report) Miru...
Benzinga Pro data, Mirum Pharmaceuticals (NASDAQ: MIRM ) reported Q4 sales of $27.91 million. Earnings fell to a loss of $36.43 million, resulting in a 2.03%...
Keybanc boosted Five Below, Inc. (NASDAQ: FIVE ) price target from $188 to $200. Keybanc analyst Bradley Thomas maintained an Overweight rating on the stock....
According to Benzinga Pro data, during Q2, Mirum Pharmaceuticals (NASDAQ: MIRM ) posted sales of $17.48 million. Earnings were up 26.45%, but Mirum Pharmaceu...